{"id":"W4282025629","doi":"10.1016/j.thromres.2022.05.014","title":"Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial","year":2022,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Nova Scotia Health Authority; Jewish General Hospital; University of Ottawa; McGill University; Queen's University; Ottawa Hospital","funders":"","keywords":"Medicine; Apixaban; Venous thromboembolism; Subgroup analysis; Intensive care medicine; Central venous catheter; Internal medicine; Clinical trial; Catheter; Cancer; Oncology; Surgery; Meta-analysis; Thrombosis; Rivaroxaban; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004219894,0.000851366,0.003139,0.0003816012,0.0004151865,0.001721805,0.0006307614,0.002281009,0.002013972],"category_scores_gemma":[0.01077756,0.0004120001,0.004861328,0.0007550173,0.0004032812,0.0006907479,0.0003635265,0.002760968,0.0004284271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007470463,"about_ca_system_score_gemma":0.0008458727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001630192,"about_ca_topic_score_gemma":0.004137218,"domain_scores_codex":[0.9969183,0.001806952,0.0004419098,0.0003318544,0.0002918,0.0002092898],"domain_scores_gemma":[0.9949632,0.002927834,0.0007582729,0.0007142776,0.0003159448,0.000320477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6286922,0.0007450245,0.1639724,0.002832822,0.08244716,0.002758967,0.0003898583,0.001271336,0.004659113,0.001176714,0.03931506,0.07173941],"study_design_scores_gemma":[0.380143,0.01936054,0.3720892,0.001225619,0.177352,0.004452217,0.0008642133,0.007818521,0.003195094,0.007987322,0.02511629,0.000395985],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9121107,0.04467608,0.000909584,0.02428334,0.004341244,0.0004178637,0.005568829,0.00007839239,0.007614096],"genre_scores_gemma":[0.9767773,0.004445166,0.0004923695,0.01119318,0.003678394,0.0002457238,0.001405072,0.00002857162,0.001734371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004219894,"threshold_uncertainty_score":0.02231717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04382775969716397,"score_gpt":0.3444161122295648,"score_spread":0.3005883525324008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}